Demo Sign up Log In

Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA)

R&D Expenses

$995.00M

TTM · Period ending: Jun 30, 2026 · USD

TEVA R&D Expenses

Latest reported$995.00Mperiod endingJun 30, 2026

Latest reported$995.00Mperiod endingJun 30, 2026

TEVA TTM R&D Expenses ($0.00 → $995.00M)

TTM R&D Expenses

High-resolution chart · PNG

TEVA r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Teva Pharmaceutical Industries Limited American Depositary Shares R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2001	113,476,000
Mar 31, 2001	112,650,000
Dec 31, 2000	104,575,000
Sep 30, 2000	95,697,000
Jun 30, 2000	87,657,000
Mar 31, 2000	82,665,000
Dec 31, 1999	81,942,000
Sep 30, 1999	76,000,000
Jun 30, 1999	76,700,000
Mar 31, 1999	71,600,000
Dec 31, 1998	68,100,000
Sep 30, 1998	52,200,000
Jun 30, 1998	31,900,000
Mar 31, 1998	15,700,000
Dec 31, 1997	0
Sep 30, 1997	0
Jun 30, 1997	0
Mar 31, 1997	0
Dec 31, 1996	0
Sep 30, 1996	0
Jun 30, 1996	0
Mar 31, 1996	0
Dec 31, 1995	0
Sep 30, 1995	0
Jun 30, 1995	0
Mar 31, 1995	0
Dec 31, 1994	0
Sep 30, 1994	0
Jun 30, 1994	0
Mar 31, 1994	0
Dec 31, 1993	0
Sep 30, 1993	0
Jun 30, 1993	0
Mar 31, 1993	0
Dec 31, 1992	0
Sep 30, 1992	0
Jun 30, 1992	0
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0
Mar 31, 1990	0
Dec 31, 1989	0
Sep 30, 1989	0
Jun 30, 1989	0
Mar 31, 1989	0
Dec 31, 1988	0
Sep 30, 1988	0
Jun 30, 1988	0
Mar 31, 1988	0
Sep 30, 1987	0
Jun 30, 1987	0
Mar 31, 1987	0
Dec 31, 1986	0
Sep 30, 1986	0
Jun 30, 1986	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.